XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.610
+0.100 (3.98%)
Mar 30, 2026, 11:42 AM EDT - Market open
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$96,800
Profits / Employee
-$630,800
Market Cap
6.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2016 | 7 | 1 | 16.67% | 2 | 5 |
| Dec 31, 2015 | 6 | 1 | 20.00% | 3 | 3 |
| Dec 31, 2014 | 5 | - | - | 3 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| IGC Pharma | 70 |
| Vistagen Therapeutics | 59 |
| Curis | 34 |
| Cue Biopharma | 29 |
| Passage Bio | 24 |
| Daré Bioscience | 23 |
| Tempest Therapeutics | 21 |
XTLB News
- 9 days ago - XTL Biopharmaceuticals (XTLB) Adjusts ADS to Ordinary Share Ratio - GuruFocus
- 9 days ago - XTL Biopharmaceuticals Announces ADS Ratio Change - GlobeNewsWire
- 4 weeks ago - XTL Biopharmaceuticals (XTLB) Faces Nasdaq Delisting Threat - GuruFocus
- 4 weeks ago - XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing - GlobeNewsWire
- 2 months ago - XTL Biopharmaceuticals Aims to Acquire Stake in NeuroNOS from Beyond Air (XAIR) - GuruFocus
- 2 months ago - XTL Update on Recent Developments - GlobeNewsWire
- 2 months ago - XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - GlobeNewsWire
- 2 months ago - XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire